Extended Data Table 3 Joint effects of cumulative doxorubicin and daunorubicin doses and other relevant risk factors on subsequent breast cancer among female five-year childhood cancer survivors

From: Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer